BlackRock’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-127,723
Closed -$50.8K 5458
2023
Q3
$50.8K Sell
127,723
-2,153
-2% -$856 ﹤0.01% 4931
2023
Q2
$89.6K Buy
129,876
+33,527
+35% +$23.1K ﹤0.01% 4860
2023
Q1
$760K Sell
96,349
-4,276
-4% -$33.7K ﹤0.01% 4333
2022
Q4
$90.6K Hold
100,625
﹤0.01% 4987
2022
Q3
$110K Hold
100,625
﹤0.01% 5063
2022
Q2
$124K Sell
100,625
-20,064
-17% -$24.7K ﹤0.01% 5084
2022
Q1
$285K Sell
120,689
-981
-0.8% -$2.32K ﹤0.01% 4938
2021
Q4
$378K Buy
121,670
+1,050
+0.9% +$3.26K ﹤0.01% 4882
2021
Q3
$490K Buy
120,620
+4,138
+4% +$16.8K ﹤0.01% 4692
2021
Q2
$564K Sell
116,482
-205,300
-64% -$994K ﹤0.01% 4594
2021
Q1
$1.67M Buy
321,782
+7,165
+2% +$37.2K ﹤0.01% 4281
2020
Q4
$2.1M Buy
314,617
+28,160
+10% +$188K ﹤0.01% 3952
2020
Q3
$2.92M Buy
286,457
+1,006
+0.4% +$10.2K ﹤0.01% 3698
2020
Q2
$3.58M Buy
+285,451
New +$3.58M ﹤0.01% 3577
2019
Q3
Sell
-1,158
Closed -$11K 5053
2019
Q2
$11K Sell
1,158
-2,932
-72% -$27.9K ﹤0.01% 4707
2019
Q1
$40K Sell
4,090
-281
-6% -$2.75K ﹤0.01% 4458
2018
Q4
$52K Sell
4,371
-80
-2% -$952 ﹤0.01% 4424
2018
Q3
$72K Buy
4,451
+181
+4% +$2.93K ﹤0.01% 4439
2018
Q2
$155K Sell
4,270
-893
-17% -$32.4K ﹤0.01% 4319
2018
Q1
$161K Buy
5,163
+795
+18% +$24.8K ﹤0.01% 4204
2017
Q4
$169K Buy
4,368
+299
+7% +$11.6K ﹤0.01% 4187
2017
Q3
$87K Buy
4,069
+890
+28% +$19K ﹤0.01% 4319
2017
Q2
$63K Buy
+3,179
New +$63K ﹤0.01% 4415